Cargando…
Investigating the Contribution of Drug-Metabolizing Enzymes in Drug-Drug Interactions of Dapivirine and Miconazole
Dapivirine (DPV) is a potent NNRTI used to prevent the sexual transmission of HIV. In a phase 1 trial (IPM 028), the concomitant use of a DPV vaginal ring and an antifungal miconazole (MIC) vaginal capsule was found to increase the systemic exposure to DPV in women, suggesting a potential for drug-d...
Autores principales: | Valicherla, Guru Raghavendra, Graebing, Phillip, Zhang, Junmei, Zheng, Ruohui, Nuttall, Jeremy, Silvera, Peter, Rohan, Lisa Cencia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706783/ https://www.ncbi.nlm.nih.gov/pubmed/34959473 http://dx.doi.org/10.3390/pharmaceutics13122193 |
Ejemplares similares
-
Transport and Permeation Properties of Dapivirine: Understanding Potential Drug-Drug Interactions
por: Zheng, Ruohui, et al.
Publicado: (2022) -
Increased Dapivirine Tissue Accumulation through Vaginal
Film Codelivery of Dapivirine and Tenofovir
por: Akil, Ayman, et al.
Publicado: (2014) -
Rational Design of a Multipurpose Bioadhesive Vaginal Film for Co-Delivery of Dapivirine and Levonorgestrel
por: Li, Jing, et al.
Publicado: (2019) -
Progress in antiretroviral drug delivery using nanotechnology
por: Mallipeddi, Rama, et al.
Publicado: (2010) -
Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost‐effectiveness
por: Glaubius, Robert, et al.
Publicado: (2019)